The process for certification:

• Make an appointment with Claudette for your confidential telehealth appointment. Call or text 860-333-8432

• You will then receive an email with a set of documents to complete, these will be reviewed during your medical appointment.

Qualifications for a Registration Certificate:

• Qualifying patient must be a Connecticut resident.

• Qualifying patient cannot be an inmate confined in a correctional institution or facility under the supervision of the Connecticut Department of Corrections.

A patient may only register for a medical marijuana certificate if they are a Connecticut resident being treated for a debilitating medical condition by a Connecticut-licensed physician, physician assistant or advanced practice registered nurse.

For Adults, Medical Conditions Include:

• Cancer (Effective 2012)

• Glaucoma (Effective 2012)

• Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (Effective 2012)

• Parkinson's Disease (Effective 2012)

• Multiple Sclerosis (Effective 2012)

• Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)

• Epilepsy (Effective 2012)

• Cachexia (Effective 2012)

• Wasting Syndrome (Effective 2012)

• Crohn's Disease (Effective 2012)

• Post-Traumatic Stress Disorder (Effective 2012)

• Sickle Cell Disease (Effective 2016)*

• Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*

• Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*

• Amyotrophic Lateral Sclerosis (Effective 2016)*

• Ulcerative Colitis (Effective 2016)*

• Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*

• Cerebral Palsy (Effective 2016)

• Cystic Fibrosis (Effective 2016)

• Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)

• Terminal Illness Requiring End-Of-Life Care (Effective 2016)

• Uncontrolled Intractable Seizure Disorder (Effective 2016)

• Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*

• Severe Rheumatoid Arthritis (Effective 2018)*

• Post Herpetic Neuralgia (Effective 2018)*

• Hydrocephalus with Intractable Headache (Effective 2018)*

• Intractable Headache Syndromes (Effective 2018)*

• Neuropathic Facial Pain (Effective 2018)*

• Muscular Dystrophy (Effective 2018)*

• Osteogenesis Imperfecta (Effective 2018)*

• Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*

• Interstitial Cystitis (Effective 2019)*

• MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*

• Vulvodynia and Vulvar Burning (Effective 2019)*

• Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*

• Tourette Syndrome (Effective 2019)*

• Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*

• Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)*

• Chronic Pancreatitis (Effective 2021)*

•  Movement disorders associated with Huntington Disease (Effective 2021)